Skip to main content
VCbacked
Log inGet Started

NeuExcell Therapeutics

State College, United States

NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.

$15.0M raised
May 2023
Seed
BiotechnologyHealth DiagnosticsMedical

Top Investors

Foothill VenturesBioVentureInnoangel FundGuangzhou Financial Holding Fund ManagementCowin Venture

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NeuExcell Therapeutics

How much funding has NeuExcell Therapeutics raised?
NeuExcell Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Who are NeuExcell Therapeutics's investors?
NeuExcell Therapeutics's investors include Foothill Ventures, BioVenture, Innoangel Fund, Guangzhou Financial Holding Fund Management, Cowin Venture.
Where is NeuExcell Therapeutics headquartered?
NeuExcell Therapeutics is headquartered in State College, United States.
What does NeuExcell Therapeutics do?
NeuExcell Therapeutics is a medical organization that provides diagnostic and research services.
What stage is NeuExcell Therapeutics at?
NeuExcell Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"NeuExcell Therapeutics — Funding & Investors." VCBacked, May 4, 2023, https://www.vcbacked.co/company/neuexcell-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). NeuExcell Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/neuexcell-therapeutics
Wikipedia (cite web)
{{cite web |title=NeuExcell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuexcell-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong